GIP receptor activation Glucose-dependent insulinotropic polypeptide (GIP) is the second receptor target, similar to tirzepatide (Mounjaro, Zepbound): Effects: Enhances insulin release from the pancreas Works synergistically with GLP-1 for appetite control May influence fat storage and energy balance Improves glucose regulation Tirzepatide's success as a dual GLP-1/GIP agonist demonstrated that adding GIP to GLP-1 enhances weight loss beyond GLP-1 alone
Our bulk options are ideal for clinical trials, research projects, or commercial manufacturing
You should not self-administer this medicine at home
Eat to Stabilize Blood Sugar While GLP-1 medications reduce hunger, pairing them with a low-carbohydrate, whole-food diet enhances glucose stability and fat burning
Take 1 or 2 films once a day
Patients love it because its only administered once a week and the effects are just amazing, Page says